Vectura sets sights on lower risk strategy
Vectura (VEC) is changing to a 'relatively lower risk' strategy as it plans to extend the partnered development of high-potential generic drugs for the US.The FTSE 250 pharma firm develops formulations and technology for dry powder...
04 January 2018